JEFFREY COOK: Open Payments
NPI 1700378403 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 17 payments from 8 companies in 2025. Trend: 2023 $498 · 2024 $608 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $115 |
| Philips North America LLC | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| PFIZER INC. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Amgen Inc. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: Ambulatory Monitoring & Diagnostics Undivided, LEQVIO, NEXLETOL, Kerendia, REPATHA, VYNDAQEL, JARDIANCE, ELIQUIS.
Industry payments across AL — which companies pay providers there.
